Technetium-99m

Technetium-99m (Tc-99m) is a metastable nuclear isomer of technetium-99, a synthetic element with a significant application in nuclear medicine. Discovered in the 1930s by Emilio Segrè and Carlo Perrier, technetium was the first artificially produced element. Tc-99m, in particular, has become the most widely used radioisotope for medical imaging due to its favourable physical and radiological properties.

The primary reason behind Tc-99m widespread use in medical diagnostics is its ideal half-life of approximately six hours. This relatively short half-life allows for the rapid decay and elimination of the radioisotope from the patient’s body, minimizing radiation exposure. Additionally, Tc-99m emits gamma rays with an energy of 140 keV, which is optimal for detection by gamma cameras and single-photon emission computed tomography (SPECT) scanners. These properties enable physicians to obtain high-quality images while ensuring patient safety.

Technetium-99m is typically produced by irradiating a molybdenum-98 (Mo-98) target in a nuclear reactor, which then undergoes a nuclear reaction to form molybdenum-99 (Mo-99). Mo-99 decays to Tc-99m with a half-life of 66 hours, making it a practical generator-produced radioisotope. The Tc-99m is extracted from the Mo-99 through a straightforward chemical process, often called a ‘molybdenum cow’ or ‘technetium generator.’ The on-demand production of Tc-99m from Mo-99 allows healthcare facilities to continuously supply the radioisotope for diagnostic procedures.

One of the major advantages of Tc-99m is its ability to be complexed with various radiopharmaceuticals, allowing it to target specific organs or tissues in the body. For instance, Tc-99m can be combined with methylene diphosphonate (MDP) to assess bone metabolism or with diethylenetriaminepentaacetic acid (DTPA) for renal imaging. These radiopharmaceuticals facilitate the accumulation of Tc-99m in the desired tissue or organ, providing essential diagnostic information through gamma-ray detection.

Tc-99m is crucial in diagnosing various diseases and conditions, including cancer, heart disease, bone disorders, and thyroid issues. Some common imaging techniques using Tc-99m include SPECT, planar imaging, and SPECT/CT. These imaging modalities enable physicians to study the structure and function of organs, identify abnormalities, and monitor the progress of treatments.

You are here:
home » technetium-99m

FDA-approved radiopharmaceuticals revolutionise diagnostics and targeted therapies, enhancing accuracy and effectiveness in disease detection and treatment.
FDA-Approved Radiopharmaceuticals

Technetium-99m Exametazime (Ceretec): Overview of its Applications, Advantages, and Role in Medical Imaging

Technetium-99m Exametazime (Ceretec): Overview of its Applications, Advantages, and Role in Medical ImagingBy | 4 minutes of reading

Technetium-99m exametazime (Ceretec) is a pivotal radiopharmaceutical in nuclear medicine, revolutionising brain imaging with high precision and reliability.

Technetium-99m Exametazime (Ceretec): Overview of its Applications, Advantages, and Role in Medical Imaging Read Article »

,